Ovarian rejuvenation treatment for low egg reserve: how it works

Ovarian rejuvenation treatment for low egg reserve refers to a group of regenerative medicine approaches designed to support ovarian function, improve egg quality, and potentially increase the number of retrievable eggs in women with diminished ovarian reserve. At Stem Rx IVF in Navi Mumbai, these therapies are offered as part of a personalised fertility programme for women who have not responded adequately to conventional stimulation protocols or who have been told their egg reserve is too low for IVF.

The underlying principle is that certain biological signals — growth factors, platelet-derived proteins, exosomes, and mitochondrial support — may activate dormant follicles or improve the cellular environment in which eggs develop. These are investigational approaches; outcomes vary by individual, and no treatment guarantees conception.

• Target population: Women with low AMH, high FSH, poor ovarian response, or premature ovarian insufficiency (POI)
• Core mechanism: Delivery of growth factors or regenerative agents directly into or around ovarian tissue to support follicular activity
• Common modalities: Platelet-rich plasma (PRP), exosome therapy, mitochondrial therapy, ovarian extracellular matrix (ECM) approaches
• Goal: Improve egg quality, increase antral follicle count, and enhance IVF outcomes where possible
• Evidence status: Emerging — clinical studies are ongoing; results are promising but not yet universally standardised

Clinical signs and markers of low ovarian reserve

Low ovarian reserve does not always produce obvious symptoms. Many women discover the condition only during fertility investigations. The following clinical signs and test results are associated with diminished ovarian reserve:

• Low AMH (Anti-Müllerian Hormone): AMH below 1.0 ng/mL is considered low by most reproductive medicine guidelines; below 0.5 ng/mL is very low. Values must always be interpreted in the context of age and other markers.
• Elevated FSH: A day-2 or day-3 FSH above 10 IU/L suggests the pituitary is working harder to stimulate the ovaries
• Low antral follicle count (AFC): Fewer than 5–7 follicles visible on transvaginal ultrasound at the start of a cycle
• Irregular or shortened menstrual cycles: Cycles shorter than 24 days can indicate accelerated follicular depletion
• Poor response to ovarian stimulation: Fewer than 3–4 eggs retrieved despite standard or high-dose gonadotrophin protocols
• History of ovarian surgery, chemotherapy, or radiation: These can reduce the follicular pool significantly
• Early menopause symptoms before age 40: Hot flushes, night sweats, and cycle irregularity in younger women may signal premature ovarian insufficiency

Causes of low egg reserve and poor ovarian response

Understanding the cause of low ovarian reserve helps determine which ovarian rejuvenation approach — if any — is most appropriate. Common causes include:

• Age-related follicular decline: Women are born with a finite number of eggs. Reserve declines progressively, with a steeper drop after age 35. The rate of decline varies considerably between individuals.
• Genetic factors: Fragile X premutation carriers and women with Turner syndrome are at higher risk of early ovarian insufficiency
• Autoimmune conditions: Autoimmune oophoritis can damage ovarian tissue and reduce follicular activity
• Previous ovarian surgery: Ovarian cystectomy for endometriomas or dermoid cysts can inadvertently remove healthy ovarian cortex
• Endometriosis: Ovarian endometriomas and the associated inflammatory environment can impair follicular development
• Chemotherapy and radiotherapy: Gonadotoxic treatments deplete the follicular pool, sometimes irreversibly
• Idiopathic (unknown cause): In a proportion of women, no identifiable cause is found
• Lifestyle and environmental factors: Smoking is associated with accelerated follicular loss; other environmental exposures are under investigation

Diagnosing low ovarian reserve before ovarian rejuvenation treatment

A thorough diagnostic workup is essential before recommending ovarian rejuvenation treatment for low egg reserve. At Stem Rx IVF, the evaluation typically includes the following assessments:

• AMH blood test: The single most reliable marker of ovarian reserve; can be measured on any day of the cycle
• Day 2–3 FSH and oestradiol: Elevated FSH with low oestradiol confirms reduced reserve; high oestradiol can mask a high FSH reading
• Transvaginal ultrasound (antral follicle count): Counts resting follicles in both ovaries; performed on days 2–5 of the menstrual cycle
• Inhibin B: A supplementary marker; low levels correlate with reduced granulosa cell activity
• Karyotype and genetic screening: Recommended when premature ovarian insufficiency is suspected, especially in women under 40
• Previous IVF stimulation records: Number of eggs retrieved and embryo quality in prior cycles provide real-world reserve data
• Autoimmune panel: Anti-ovarian antibodies may be checked when autoimmune oophoritis is a differential

Results from these tests are interpreted together — no single marker is sufficient to make a definitive diagnosis or treatment decision. Use the booking form on this page to arrange a diagnostic consultation at Stem Rx IVF, Navi Mumbai.

Ovarian rejuvenation treatment options: a comparison

Several regenerative approaches are used in ovarian rejuvenation. The table below summarises the main options available at Stem Rx IVF, along with key considerations. These are emerging therapies; suitability is determined on a case-by-case basis.

Improving egg quality through optimised nutrition, antioxidant supplementation, and lifestyle modification is often recommended alongside these clinical interventions. Meaningful changes in egg quality take approximately 3 months, reflecting the duration of the follicular maturation cycle. This is why reassessment of AMH and AFC is typically scheduled at the 3-month mark after any ovarian rejuvenation procedure.

When to consult a fertility specialist about low egg reserve

Seek a specialist consultation at Stem Rx IVF, Navi Mumbai, if any of the following apply:

• You have been trying to conceive for 6 months or more and are aged 35 or above, or for 12 months if under 35, without success
• Your AMH result is below 1.0 ng/mL at any age, or below 1.5 ng/mL if you are under 35
• A previous IVF cycle retrieved fewer than 4 eggs despite standard or high-dose stimulation
• You have been diagnosed with premature ovarian insufficiency or have experienced menopause-like symptoms before age 40
• You have a history of ovarian surgery, endometriosis, chemotherapy, or radiotherapy and wish to conceive
• Your day-3 FSH is above 10 IU/L on two or more separate cycles
• You have received a report of poor embryo quality in a prior IVF cycle despite adequate egg numbers

Early consultation allows more time to explore all available options, including ovarian rejuvenation, endometrial rejuvenation, and tailored IVF protocols, before the window of opportunity narrows further.

Stem Rx IVF Navi Mumbai: regenerative fertility care for low egg reserve

Stem Rx IVF, located at Dr. Mahajan's Hospital on Thane–Belapur Road, Rabale, Navi Mumbai, integrates regenerative medicine with conventional assisted reproduction to offer a more comprehensive approach for women with diminished ovarian reserve. Rather than immediately advising donor eggs, the team evaluates whether regenerative interventions — PRP, exosome therapy, mitochondrial support, or ovarian ECM approaches — may improve the patient's own egg quality and reserve before or alongside an IVF cycle.

Every fertility journey at Stem Rx IVF begins with a thorough diagnostic review. Treatment plans are personalised based on AMH, AFC, age, reproductive history, and the specific cause of low reserve. The clinic's access to advanced regenerative protocols, combined with its ovarian rejuvenation programme, means patients with complex or previously failed cases have access to options that go beyond standard IVF stimulation.